Next-generation community genetics for low- and middle-income countries

Genome Medicine

Volumn 4, Issue 3, 2012, Pages

  Kingsmore, Stephen F ^a   Lantos, John D ^a   Dinwiddie, Darrell L ^a   Miller, Neil A ^a   Soden, Sarah E ^a   Farrow, Emily G ^a   Saunders, Carol J ^a  

^a CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Community genetics; Low income countries; Mendelian disease; Multiplexing; Newborn screening; Next generation sequencing; Preconception carrier testing

Indexed keywords

ARTICLE; BETA THALASSEMIA; COMMUNITY GENETICS; CYSTIC FIBROSIS; DUCHENNE MUSCULAR DYSTROPHY; ENVIRONMENTAL FACTOR; FRAGILE X SYNDROME; GENE TECHNOLOGY; GENETIC COUNSELING; GENETIC DISORDER; GENETIC VARIABILITY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH EDUCATION; HEMOPHILIA A; HOMOGENATE; HUMAN; LOW AND MIDDLE INCOME COUNTRY; LOWEST INCOME GROUP; MENDELIAN RANDOMIZATION ANALYSIS; NEWBORN SCREENING; NEXT GENERATION SEQUENCING; PERSONAL AUTONOMY; PHENYLKETONURIA; POPULATION GENETICS; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SICKLE CELL ANEMIA; SOCIAL STATUS; SPINAL MUSCULAR ATROPHY; TAY SACHS DISEASE;

EID: 84858981006     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm324     Document Type: Article

References (55)

1. World Health Organization Community Genetics Services: Report of a WHO Consultation on Community Genetics in Low- and Middle-Income Countries Geneva. 2011, World Health Organization.
2. Alwan A, Modell B. Recommendations for introducing genetics services in developing countries. Nat Rev Genet 2003, 4:61-68.
3. Christianson A, Howson CP, Modell B. March of Dimes Global Report on Birth Defects: The Hidden Toll of Dying and Disabled Children 2006, White Plains, NY: March of Dimes Birth Defects Foundation., http://www.marchofdimes.com/downloads/Birth_Defects_Report-PF.pdf
4. Institute of Medicine Rare Diseases and Orphan Products: Accelerating Research and Development 2010, Washington, Institute of Medicine., http://www.iom.edu/Reports/2010/Rare-Diseases-and-Orphan-Products-Accelerating-Research-and-Development.aspx
5. Aliyu ZY, Kato GJ, Taylor J 6, Babadoko A, Mamman AI, Gordeuk VR, Gladwin MT. Sickle cell disease and pulmonary hypertension in Africa: a global perspective and review of epidemiology, pathophysiology, and management. Am J Hematol 2008, 83:63-70. 10.1002/ajh.21057, 17910044.
6. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008, 86:480-487. 2647473, 18568278.
7. Segeja MD, Mmbando BP, Kamugisha ML, Akida JA, Savaeli ZX, Minja DT, Msangeni HA, Lemnge MM. Prevalence of glucose-6-phosphate dehydrogenase deficiency and haemoglobin S in high and moderate malaria transmission areas of Muheza, north-eastern Tanzania. Tanzan J Health Res 2008, 10:9-13.
8. Chattopadhyay S. 'Rakter dosh' - corrupting blood: The challenges of preventing thalassemia in Bengal, India. Soc Sci Med 2006, 63:2661-2673. 10.1016/j.socscimed.2006.06.031, 16901596.
9. Alswaidi FM, O'Brien SJ. Premarital screening programmes for haemoglobinopathies, HIV and hepatitis viruses: review and factors affecting their success. J Med Screen 2009, 16:22-28. 10.1258/jms.2008.008029, 19349527.
10. Zlotogora J. Population programs for the detection of couples at risk for severe monogenic genetic diseases. Hum Genet 2009, 126:247-253. 10.1007/s00439-009-0669-y, 19390864.
11. Hamamy H, Al-Hait S, Alwan A, Ajlouni K. Jordan: communities and community genetics. Community Genet 2007, 10:52-60. 10.1159/000096282, 17167252.
12. Kaback M, Lim-Steele J, Dabholkar D, Brown D, Levy N, Zeiger K. Tay-Sachs disease-carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network. JAMA 1993, 270:2307-2315. 10.1001/jama.1993.03510190063028, 8230592.
13. Kaback MM. Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model. Eur J Pediatr 2000, 159(Suppl 3):S192-195.
14. Ekstein J, Katzenstein H. The Dor Yeshorim story: community-based carrier screening for Tay-Sachs disease. Adv Genet 2001, 44:297-310.
15. National Human Genome Research Institute Summary of Population-based Carrier Screening for Single Gene Disorders: Lessons Learned and New Opportunities. 2008, National Human Genome Research Institute., http://www.genome.gov/27026048#3
16. Bayoumi RA, Yardumian A. Genetic disease in the Arab world. BMJ 2006, 333:819. 10.1136/bmj.39002.350405.80, 1618432, 17053218.
17. Khorasani G, Kosaryan M, Vahidshahi K, Shakeri S, Nasehi MM. Results of the national program for prevention of beta-thalassemia major in the Iranian Province of Mazandaran. Hemoglobin 2008, 32:263-271. 10.1080/03630260802004269, 18473242.
18. Memish ZA, Saeedi MY. Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and beta-thalassemia in Saudi Arabia. Ann Saudi Med 2011, 31:229-235. 10.4103/0256-4947.81527, 3119961, 21623050.
19. Hamamy H, Antonarakis SE, Cavalli-Sforza LL, Temtamy S, Romeo G, Kate LP, Bennett RL, Shaw A, Megarbane A, van Duijn C, Bathija H, Fokstuen S, Engel E, Zlotogora J, Dermitzakis E, Bottani A, Dahoun S, Morris MA, Arsenault S, Aglan MS, Ajaz M, Alkalamchi A, Alnaqeb D, Alwasiyah MK, Anwer N, Awwad R, Bonnefin M, Corry P, Gwanmesia L, Karbani GA, et al. Consanguineous marriages, pearls and perils: Geneva International Consanguinity Workshop Report. Genet Med 2011, 13:841-847. 10.1097/GIM.0b013e318217477f, 21555946.
20. Zlotogora J, Shalev SA. The consequences of consanguinity on the rates of malformations and major medical conditions at birth and in early childhood in inbred populations. Am J Med Genet A 2010, 152A:2023-2028. 10.1002/ajmg.a.33537, 20635393.
21. Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, Langley RJ, Zhang L, Lee CC, Schilkey FD, Sheth V, Woodward JE, Peckham HE, Schroth GP, Kim RW, Kingsmore SF. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Science Transl Med 2011, 3:65ra4.
22. Watson MS L-PM, Mann MY, Rinaldo P, Howell RR. Newborn screening: toward a uniform screening panel and system. Genet Med 2006, 8(Suppl 1):1S-252S. 3111605, 16783161.
23. Therrell B, Lorey F, Eaton R, Frazier D, Hoffman G, Boyle C, Green D, Devine O, Hannon H. Impact of Expanded Newborn Screening - United States, 2006. MMWR Morb Mortal Wkly Rep 2008, 57:1012-1015.
24. Health Resources and Services Administration Secretary's Advisory Committee on Heritable Disorders in Newborns and Children 2011 Annual Report to Congress 2011, Rockville, MD, Health Resources and Services Administration., http://www.hrsa.gov
25. al-Hosani H, Salah M, Saade D, Osman H, al-Zahid J. United Arab Emirates National Newborn Screening Programme: an evaluation 1998-2000. East Mediterr Health J 2003, 9:324-332.
26. Saadallah AA, Rashed MS. Newborn screening: experiences in the Middle East and North Africa. J Inherit Metab Dis 2007, 30:482-489. 10.1007/s10545-007-0660-5, 17701444.
27. National Human Genome Research Institute DNA Sequencing Costs. Data from the NHGRI Large-Scale Genome Sequencng Program National Human Genome Research Institute., http://www.genome.gov/images/content/cost_per_megabase.jpg
28. GeneTests: Medical Genetics Information Resource. , http://www.genetests.org
29. Kingsmore SF, Saunders CJ. Deep sequencing of patient genomes for disease diagnosis: when will it become routine?. Sci Transl Med 2011, 3:87ps23. 10.1126/scitranslmed.3002695, 21677196.
30. Kingsmore SF, Dinwiddie DL, Miller NA, Soden SE, Saunders CJ. Adopting orphans: comprehensive genetic testing of Mendelian diseases of childhood by next-generation sequencing. Expert Rev Mol Diagn 2011, 11:855-868. 10.1586/erm.11.70, 22022947.
31. Inati A, Zeineh N, Isma'eel H, Koussa S, Gharzuddine W, Taher A. Beta-thalassemia: the Lebanese experience. Clin Lab Haematol 2006, 28:217-227. 10.1111/j.1365-2257.2006.00792.x, 16898958.
32. World Health Organization Management of Haemoglobin Disorders World Health Organization., http://www.who.int/genomics/WHO-TIF_genetics_final.pdf
33. Hamamy H, Alwan A. Hereditary disorders in the Eastern Mediterranean region. Bull World Health Organ 1994, 72:145-154. 2486500, 8131251.
34. Charafeddine K, Isma'eel H, Charafeddine M, Inati A, Koussa S, Naja M, Taher A. Survival and complications of beta-thalassemia in Lebanon: a decade's experience of centralized care. Acta Haematol 2008, 120:112-116. 10.1159/000171088, 19001806.
35. Frossard PM, Lestringant G, Girodon E, Goossens M, Dawson KP. Determination of the prevalence of cystic fibrosis in the United Arab Emirates by genetic carrier screening. Clin Genet 1999, 55:496-497. 10.1034/j.1399-0004.1999.550618.x, 10450871.
36. Delea TE, Hagiwara M, Thomas SK, Baladi JF, Phatak PD, Coates TD. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States. Am J Hematol 2008, 83:263-270. 10.1002/ajh.21049, 17924547.
37. Koren A, Zalman L, Palmor H, Zamir RB, Levin C, Openheim A, Daniel-Spiegel E, Shalev S, Filon D. Sickle cell anemia in northern Israel: screening and prevention. Isr Med Assoc J 2009, 11:229-234.
38. Srinivasan BS, Evans EA, Flannick J, Patterson AS, Chang CC, Pham T, Young S, Kaushal A, Lee J, Jacobson JL, Patrizio P. A universal carrier test for the long tail of Mendelian disease. Reprod Biomed Online 2010, 21:537-551. 10.1016/j.rbmo.2010.05.012, 20729146.
39. Wilson JMG, Jungner G. Principles and Practice of Screening for Disease. Geneva 1968, 34. World Heath Organization; Public Health Papers No.
40. The Human Genetics Commission Increasing Options, Informing Choice: A Report on Preconception Genetic Testing and Screening. London 2011, The Human Genetics Commission.
41. Kingsmore SF, Lindquist IE, Mudge J, Gessler DD, Beavis WD. Genome-wide association studies: progress and potential for drug discovery and development. Nat Rev Drug Discov 2008, 7:221-230. 10.1038/nrd2519, 2853477, 18274536.
42. Altshuler D, Daly MJ, Lander ES. Genetic mapping in human disease. Science 2008, 322:881-888. 10.1126/science.1156409, 2694957, 18988837.
43. Ropers HH. Genetics of early onset cognitive impairment. Annu Rev Genomics Hum Genet 2010, 11:161-187. 10.1146/annurev-genom-082509-141640, 20822471.
44. Najmabadi H, Hu H, Garshasbi M, Zemojtel T, Abedini SS, Chen W, Hosseini M, Behjati F, Haas S, Jamali P, Zecha A, Mohseni M, Püttmann L, Vahid LN, Jensen C, Moheb LA, Bienek M, Larti F, Mueller I, Weissmann R, Darvish H, Wrogemann K, Hadavi V, Lipkowitz B, Esmaeeli-Nieh S, Wieczorek D, Kariminejad R, Firouzabadi SG, Cohen M, Fattahi Z, et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 2011, 478:57-63. 10.1038/nature10423, 21937992.
45. Firdous N. Prevention of thalassaemia and haemoglobinopathies in remote and isolated communities - the Maldives experience. Ann Hum Biol 2005, 32:131-137. 10.1080/03014460500074996, 16096208.
46. Farrell PM. The prevalence of cystic fibrosis in the European Union. J Cyst Fibros 2008, 7:450-453. 10.1016/j.jcf.2008.03.007, 18442953.
47. Tuncbilek E, Ozguc M. Application of medical genetics in Turkey. Turk J Pediatr 2007, 49:353-359.
48. Okwi AL, Byarugaba W, Ndugwa CM, Parkes A, Ocaido M, Tumwine JK. An up-date on the prevalence of sickle cell trait in Eastern and Western Uganda. BMC Blood Disord 2010, 10:5. 10.1186/1471-2326-10-5, 2905339, 20569434.
49. Kvasnicová M, Styková J, Hudec P. [Incidence of spinal muscular atrophy and Duchenne's muscular dystrophy in the juvenile population of central Slovakia]. Bratisl Lek Listy 1994, 95:78-82.
50. Emery AE. Population frequencies of inherited neuromuscular diseases - a world survey. Neuromuscul Disord 1991, 1:19-29. 10.1016/0960-8966(91)90039-U, 1822774.
51. Hantash FM, Goos DM, Crossley B, Anderson B, Zhang K, Sun W, Strom CM. FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: insights into the prevalence of fragile × syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States. Genet Med 2011, 13:39-45. 10.1097/GIM.0b013e3181fa9fad, 21116185.
52. Hassan MK, Taha JY, Al-Naama LM, Widad NM, Jasim SN. Frequency of haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in Basra. East Mediterr Health J 2003, 9:45-54.
53. Stonebraker JS, Bolton-Maggs PH, Soucie JM, Walker I, Brooker M. A study of variations in the reported haemophilia A prevalence around the world. Haemophilia 2010, 16:20-32.
54. Online Mendelian Inheritence in Man. , http://www.ncbi.nlm.nih.gov/omim
55. Hamamy H, Bittles AH. Genetic clinics in Arab communities: meeting individual, family and community needs. Public Health Genomics 2009, 12:30-40.